What were HCA Healthcare's (NYSE:HCA) total revenue and net income for Q1 2026?

HCA Healthcare reported total revenue of $19.109 billion for Q1 2026, a 4.3% increase compared to the same period last year. Net income attributable to HCA Healthcare edged up slightly to $1.620 billion.

How did HCA Healthcare’s diluted earnings per share (EPS) perform in Q1 2026?

Diluted EPS for Q1 2026 surged 10.9% to $7.15, benefiting from HCA’s aggressive share repurchase program.

What operational metrics drove HCA Healthcare’s performance in Q1 2026?

HCA Healthcare saw positive operational metrics, including a 0.9% increase in same-facility admissions and a 1.3% rise in same-facility equivalent admissions year-over-year.

How is HCA Healthcare expanding its network in 2026?

HCA Healthcare continues to expand its network, which now includes 189 hospitals and approximately 2,600 ambulatory sites of care.

Image for illustrative purposes only. Not a real photo.

HCA Healthcare profits rise as resilient admissions growth offsets cost pressures

Written by Jon CuthbertPublished Apr 24, 2026, 12:00 AMLast Updated Jul 6, 2026, 10:29 AM

HCA Healthcare (NYSE:HCA) posted a solid start to 2026, delivering a double-digit increase in earnings per share as steady patient volumes and operational "resiliency" initiatives helped the hospital giant navigate a complex reimbursement landscape.

The Nashville-based healthcare provider (NYSE:HCA) reported first-quarter revenue of $19.109 billion, a 4.3% increase compared to the $18.318 billion recorded in the same period last year.

Net income attributable to HCA Healthcare edged up slightly to $1.620 billion.

However, diluted earnings per share (EPS)—and diluted EPS as adjusted—surged 10.9% to $7.15, benefiting from the company’s aggressive share repurchase program.

Operational metrics remained positive, with same-facility admissions growing 0.9% and same-facility equivalent admissions increasing 1.3% year-over-year.

The growth comes as HCA continues to expand its network, which currently includes 189 hospitals and approximately 2,600 ambulatory sites of care.

Adjusted EBITDA for the quarter rose 1.9% to $3.802 billion, reflecting the company's ability to manage labor costs and inflationary pressures.

The company’s financial position was bolstered by a significant 22% jump in cash flows from operating activities, which reached $2.014 billion for the quarter.

This liquidity supported HCA's continued commitment to returning value to shareholders; the company paid a quarterly dividend of $0.78 per share on March 31 and remains active under its $10 billion share repurchase authorization announced earlier this year.

HCA also maintained its full-year 2026 guidance, which projects total revenues between $76.5 billion and $80 billion and diluted EPS in the range of $29.10 to $31.50.